Predictive power of glycated hemoglobin in detecting severity of coronary artery disease in non-diabetic patients: A cross-sectional study in southern Iran

Abbaszadeh, Shahin; Rafati, Shideh; Mamikhani, Daryoush; Emami, Mahdieh; Shahabi, Nahid

doi:10.48305/arya.2024.42463.2936

Document Type : Original Article

Authors

¹ Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

² Social Determinants in Health Promotion Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

³ Independent Researcher, Private Clinic, Chalus, Iran

https://doi.org/10.48305/arya.2024.42463.2936

Abstract

BACKGROUND: The relationship between hemoglobin A1c (HbA1c) levels and coronary artery disease (CAD) severity is still a matter of debate in non-diabetic patients. This study aimed to determine the association between HbA1c and the severity of CAD in non-diabetic patients.
METHODS: The present cross-sectional study was conducted in 2018-2019 on 133 non-diabetic patients with stable angina, unstable angina, or myocardial infarction (MI). They were selected through systematic random sampling. The data were collected by taking a complete medical history, calculating the SYNTAX score, and measuring HbA1c.
RESULTS: A SYNTAX score of >22 was significantly correlated with age, left ventricular ejection fraction, HbA1c, and total cholesterol. The mean SYNTAX score was higher in male patients, those with HbA1c >5.6, and patients with a primary clinical presentation of MI. The association between the SYNTAX score and HbA1c was found to be statistically significant (r = 0.659; P < .001). The odds of having a SYNTAX score of >22 for those with HbA1c >5.6 was 5.48 times higher than for those with HbA1c ≤ 5.6 (odds ratio [OR], 5.48; P < .001). The odds of three-vessel disease in individuals with an HbA1c level greater than 5.6 were found to be 4.80 times higher than in those with HbA1c levels at or below 5.6 (OR, 4.80; P = 0.002).
CONCLUSION: The present findings showed that HbA1c has the potential to predict the severity of CAD in non-diabetic individuals. HbA1c, even at levels within the normal range, was significantly correlated with SYNTAX scores.
Keywords: Coronary artery disease; Glycated hemoglobin; SYNTAX score; Diabetes mellitus; Iran

Keywords

References

1. WHO. Cardiovascular diseases (CVDs): fact sheet. World Health Organization. 2021.

2. Daponte-Codina A, Knox EC, Mateo-Rodriguez I, Seims A, Regitz-Zagrosek V, Maas A, et al. Gender and Social Inequalities in Awareness of Coronary Artery Disease in European Countries. Int J Environ Res Public Health. 2022 Jan 26;19(3):1388. https://doi.org/10.3390/ijerph19031388

3. Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Thomas Gerhardt declares no relevant financial relationships with ineligible companies. Disclosure: Edward Kwon declares no relevant financial relationships with ineligible companies.: StatPearls Publishing. Copyright © 2023, StatPearls Publishing LLC.; 2023.

4. Sarrafzadegan N, Mohammmadifard N. Cardiova-scular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Arch Iran Med. 2019 Apr 1;22(4):204-10.

5. Nikparvar M, Farshidi H, Madani A, Azad M, Eftekhaari TE, Ghanbarnejad A, et al. Prevalence, awareness, treatment, and control of hypertension in Hormozgan Province, Iran. Int Cardiovasc Res J. 2019;13(3):91-5.

6. Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, et al. RRisk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Arch Cardiovasc Dis. 2021 Feb;114(2):150-72. https://doi.org/10.1016/j.acvd.2020.07.003

7. Ewid M, Sherif H, Billah SMB, Saquib N, AlEnazy W, Ragab O, et al. Glycated hemoglobin predicts coronary artery disease in non-diabetic adults. BMC Cardiovasc Disord. 2019 Dec 21;19(1):309. https://doi.org/10.1186/s12872-019-01302-5

8. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med. 2018 Apr 17;168(8):569-76. https://doi.org/10.7326/m17-0939

9. Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, et al. Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study. Circulation. 2022 Sep 27;146(13):995-1005. https://doi.org/10.1161/circulationaha.122.059430

10. Sanlialp SC, Sanlialp M. Should We Use Fasting Glucose and the Glycated Hemoglobin (HbA1c) in Evaluation of Coronary Artery Disease? Angiology. 2022 Feb;73(2):182-3. https://doi.org/10.1177/00033197211026418

11. Jiao X, Zhang Q, Peng P, Shen Y. HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease. Diabetol Metab Syndr. 2023 Mar 20;15(1):50. https://doi.org/10.1186/s13098-023-01015-y

12. Khan FR, Ali J, Ullah R, Hassan Z, Khattak S, Lakhta G, et al. Relationship Between High Glycated Hemoglobin and Severity of Coronary Artery Disease in Type II Diabetic Patients Hospitalized With Acute Coronary Syndrome. Cureus. 2021 Mar 6;13(3):e13734. https://doi.org/10.7759/cureus.13734

13. Ruzicic D, Mirkovic MM. HbA1C modified Clinical SYNTAX score as a prognostic tool in patients with diabetes mellitus and multi-vessel coronary artery disease treated with primary percutaneous coronary intervention. Eur Heart J. 2020;41(Suppl_2):ehaa946.1325. https://doi.org/10.1093/ehjci/ehaa946.1325

14. Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 Aug;1(2):219-27.

15. Safarian H, Alidoosti M, Shafiee A, Salarifar M, Poorhosseini H, Nematipour E. The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention. Heart Views. 2014 Oct-Dec;15(4):99-105. https://doi.org/10.4103/1995-705x.151081

16. Marso SP. 23 - Revascularization Approaches. In: de Lemos JA, Omland T, editors. Chronic Coronary Artery Disease: Elsevier; 2018. p. 337-54.

17. Habib S, Ullah SZ, Saghir T, Muhammad AS, Deen ZU, Naseeb K, et al. The Association between Hemoglobin A1c and the Severity of Coronary Artery Disease in Non-diabetic Patients with Acute Coronary Syndrome. Cureus. 2020 Jan 12;12(1):e6631. https://doi.org/10.7759/cureus.6631

18. Ghaffari S, Niafar F, Separham A, Niafar M, Pourafkari L, Nader ND. Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients. Ther Adv Cardiovasc Dis. 2015 Oct;9(5):305-13. https://doi.org/10.1177/1753944715585500

19. Farrag A, Ammar W, Hady AE, Samhoon NE. Haemoglobin A1c as a marker predicting extent and severity of coronary artery disease in non-diabetic patients. Acta Cardiol. 2016;71(5):581-5. https://doi.org/10.2143/ac.71.5.3167502

20. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. https://doi.org/10.2337/dc22-s002

21. Karadeniz M, Duran M, Akyel A, Yarlıoğlueş M, Öcek AH, Çelik İE, et al. High Sensitive CRP Level Is Associated With Intermediate and High Syntax Score in Patients With Acute Coronary Syndrome. Int Heart J. 2015;56(4):377-80. https://doi.org/10.1536/ihj.14-299

22. Sharma C, Ojha C, editors. Statistical parameters of hydrometeorological variables: standard deviation, SNR, skewness and kurtosis. Advances in water resources engineering and management: select proceedings of TRACE 2018; 2020: Springer.

23. Orcan F. Parametric or non-parametric: skewness to test normality for mean comparison. Int J Assess Tools Educ. 2020;7(2):255-65. https://doi.org/10.21449/ijate.656077

24. Mishra P, Pandey CM, Singh U, Gupta A, Sahu C, Keshri A. Descriptive statistics and normality tests for statistical data. Ann Card Anaesth. 2019 Jan-Mar;22(1):67-72. https://doi.org/10.4103/aca.aca_157_18

25. Dykun I, Bayturan O, Carlo J, Nissen SE, Kapadia SR, Tuzcu EM, et al. HbA1c, Coronary atheroma progression and cardiovascular outcomes. Am J Prev Cardiol. 2022 Jan 18;9:100317. https://doi.org/10.1016/j.ajpc.2022.100317

26. Xu M, Chen H, Li HW. The association between SYNTAX score and long-term outcomes in patients with unstable angina pectoris: a single-centre retrospective study. BMC Cardiovasc Disord. 2022 Apr 7;22(1):155. https://doi.org/10.1186/s12872-022-02604-x

27. Fuchs FC, Ribeiro JP, Fuchs FD, Wainstein MV, Bergoli LC, Wainstein RV, et al. Syntax Score and Major Adverse Cardiac Events in Patients with Suspected Coronary Artery Disease: Results from a Cohort Study in a University-Affiliated Hospital in Southern Brazil. Arq Bras Cardiol. 2016 Sep;107(3):207-15. https://doi.org/10.5935/abc.20160111

28. Kayali Y, Ozder A. Glycosylated hemoglobin A1c predicts coronary artery disease in non-diabetic patients. J Clin Lab Anal. 2021 Feb;35(2):e23612. https://doi.org/10.1002/jcla.23612

29. Pai JK, Cahill LE, Hu FB, Rexrode KM, Manson JE, Rimm EB. Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women. J Am Heart Assoc. 2013 Mar 22;2(2):e000077. https://doi.org/10.1161/jaha.112.000077

30. Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C, Rodriguez-Artalejo F, Martínez-Vizcaíno V. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017 Jul 31;7(7):e015949.. https://doi.org/10.1136/bmjopen-2017-015949

31. Ul-Haque I, Deen ZU, Shafique S, Rehman SIU, Zaman M, Basalat ST, et al. The Role of Glycated Hemoglobin A1c in Determining the Severity of Coronary Artery Disease in Diabetic and Non-Diabetic Subjects in Karachi. Cureus. 2019 Jun 24;11(6):e4982. https://doi.org/10.7759/cureus.4982

ARYA Atherosclerosis Journal

Predictive power of glycated hemoglobin in detecting severity of coronary artery disease in non-diabetic patients: A cross-sectional study in southern Iran

References

References

Volume 20, Issue 5
September and October 2024
Pages 15-24

Predictive power of glycated hemoglobin in detecting severity of coronary artery disease in non-diabetic patients: A cross-sectional study in southern Iran

References

References

Volume 20, Issue 5September and October 2024Pages 15-24

Volume 20, Issue 5
September and October 2024
Pages 15-24